CELLIVERY
R&D
INTELLECTUAL PROPRIETARY
"Cellivery is Patentee"
| # | Target | Indication and Use | Application Number | Date | Registration Number/ Date |
|---|---|---|---|---|---|
| 01 | aMTDs | aMTD/TSDT Platform [PCT/KR2015/008544] |
|||
| CN (201580044116.8) | 17.02.16 | ||||
| JP (2017-510405) | 17.02.15 | 6559227 (19.08.14) | |||
| US (15/503117) | 17.02.10 | 10323063 (19.06.18) | |||
| CA (2957501) | 17.02.07 | 2957501 (20.08.11) | |||
| KR (10-2017-7005079) | 17.02.22 | 101971021 (19.04.23) | |||
| EP (15833496.1) | 17.02.13 | 등록결정/등록번호 미정 | |||
| AU (2015304194) | 17.01.12 | 2015304194 (18.03.01) | |||
| 02 | iCP-SOCS3 | ||||
| Pancreatic Cancer Therapy [PCT/KR2016/009416] |
EP (16839623.2) | 18.03.13 | |||
| US (15/408123) | 17.01.17 | 10781241 (20.09.22) | |||
| Solid Tumor Therapy [PCT/KR2016/009414] |
EP (16839621.6) | 18.03.15 | |||
| US (15/361701) | 16.11.28 | ||||
| CIP-DIV US (16/426751) | 19.05.30 | 등록결정/등록번호 | |||
| Anti-Angiogenesis Therapy [PCT/KR2016/009456] |
EP (16839637.2) | 18.03.16 | 등록결정/등록번호 미정 | ||
| US (15/631982) | 17.06.23 | 10787492 (20.09.29) | |||
| Hepatocellular Carcinoma Therapy [PCT/KR2016/009446] |
US (15/432662) | 17.02.14 | 10385103 (19.08.20) | ||
| Lung Cancer Therapy [PCT/KR2016/009441] |
US (15/408230) | 17.01.17 | |||
| CIP-DIV US (16/426864) | 19.05.30 | ||||
| 03 | iCP-Parkin | Parkinson's Disease Therapy [PCT/KR2016/008174] |
|||
| CN (201680044600.5) | 18.04.03 | ||||
| JP (2018-503759) | 18.01.25 | 06664464 (20.02.20) | |||
| US (15/879664) | 18.01.25 | 10662419 (20.05.26) | |||
| CA (2993778) | 18.01.25 | 2993778 (20.09.22) | |||
| KR (10-2018-7005889) | 18.02.27 | 1021323110000 (20.07.03) | |||
| EP (16830820.3) | 18.02.27 | 03328996 (20.04.01) | |||
| AU (2016299468) | 18.01.17 | 2016299468(19.07.25) | |||
| IN (201827002920) | 18.01.24 | ||||
| 04 | CP-BMP2 | Bone Healing Therapy [PCT/KR2016/009405] |
|||
| EP (16839619.0) | 18.03.12 | 03341400 (20.10.21) | |||
| US (15/884884) | 18.01.31 | 10774123 (20.09.15) | |||
| DIV US (16/831520) | 20.03.26 | ||||
| 05 | CP-△SOCS3 | Obesity Therapy [PCT/KR2016/008831] |
|||
| EP (16837265.4) | 18.03.07 | 등록결정/등록번호 미정 | |||
| US (15/888459) | 18.02.05 | 10323072 (19.06.18) | |||
| DIV US (16/382963) | 19.04.12 | 10689424 (20.06.23) | |||
| 06 | iCP-Cre | Genome Engineering Enzyme [PCT/KR2016/008760] |
|||
| EP (16835419.9) | 18.03.02 | 03334756 (20.06.17) | |||
| US (15/887414) | 18.02.02 | 10669531 (20.06.02) | |||
| 07 | iCP-RFs | iPSC Reprogramming Factors [PCT/KR2016/008757] |
|||
| EP (16835416.5) | 18.03.02 | 03334755 (20.04.08) | |||
| US (15/884651) | 18.01.31 | 10508265 (19.12.17) | |||
| 08 | CP-Cas9 | Genome Editing Enzyme [PCT/KR2017/010747] |
|||
| EP (17856752.5) | 19.03.14 | ||||
| US (16/337250) | 19.03.27 | ||||
| 09 | iCP-NI | Cytokine Storm Suppressing Anti-Sepsis Agent | |||
| US (62/977832) | 20.02.18 | ||||
| 10 | CP-SP | SOCS3 69-96 Peptide, Anti-Obesity Agent | |||
| US (63/074703) | 20.09.04 | ||||
| 11 | iCP-mParkin | modified Parkin, Anti-Neurodegenerative Disorder Agent | |||
| US (63/074697) | 20.09.04 |